bpc 157 for rotator cuff tear Peptide Therapy & Shoulder Surgery Can BPC-157 Heal a SLAP

Not the dosing protocol

This phased approach helps raise serum levels from a deficient state ( 500 pg/mL ) in just a matter of weeks

BPC-157 tackles this problem directly by: Stimulating neoangiogenesis within the tendon or ligament substance Activating tenocytes (tendon cells) to produce organized collagen Reducing fibrotic adhesion formation that limits range of motion Condition-by-Condition Clinical Applications Tendinopathies Chronic tendon conditionsAchilles, patellar, rotator cuff, lateral epicondyle (tennis elbow), medial epicondyle (golfers elbow)respond exceptionally well to BPC-157

The authors suggested that this may be due to heightened awareness of infectious complications in recent trials or that newer non-TNF- blocking agents have a lower risk for opportunistic infections